ArticleJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology2026
Correlation Between Prognostic Indicators, HPV Status, and Cancer Stem Cell Markers in a Population of Human Tongue Carcinomas.
Article in Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOral squamous cell carcinoma (OSCC) is a significant public health issue. While tobacco and alcohol are established risk factors, the role of human papillomavirus (HPV) in oral carcinogenesis remains debated. Cancer stem cells (CSCs) are implicated in tumor aggressiveness and therapy resistance. This study investigated the correlation between HPV infection, CSC marker expression (CD44, CD98, ALDH1), and clinicopathological parameters in tongue SCCs.
methodsA retrospective cohort of 1047 OSCC cases (2013-2018) was reviewed. From 452 tongue SCCs, 83 formalin-fixed paraffin-embedded specimens were randomly selected. HPV DNA detection was performed using qPCR with generic and type-specific primers (HPV 6, 11, 16, 18). Immunohistochemical expression of CD44, CD98, and ALDH1 was evaluated and quantified using digital image analysis (IHC Profiler). Statistical analyses included Kaplan-Meier survival curves, Kruskal-Wallis, Chi-square, and Spearman correlation tests.
resultsHPV DNA was detected in 2/83 cases (2.4%): one HPV16-positive and one with co-infection (HPV6/18). CD44 expression was ubiquitously high, with no significant difference between -High and -Positive categories (p > 0.9999), but both were significantly higher than -Low and -Negative scores (p < 0.0001). ALDH1 exhibited a focal staining pattern. The ALDH1-High score was significantly less frequent than -Positive and -Low scores (p < 0.01) and showed a significant positive correlation with both advanced clinical stage (Spearman r: 0.5062; p = 0.0007) and higher tumor grade (Spearman r: 0.3352; p = 0.0322). CD98 was not detected. An inverse correlation was observed between HPV and clinical staging (Spearman r: -0.2377; p = 0.0305); however, due to the low number of HPV-positive cases, this finding must be interpreted with caution.
conclusionOur findings suggest a distinct CSC expression profile in this cohort, characterized by ubiquitous CD44 expression and a rare but highly aggressive ALDH1-High subpopulation, concomitant with low HPV detection. The strong positive correlation of ALDH1-High score with advanced stage and grade highlights its potential role as a key driver of tumor aggression, warranting further investigation as a prognostic marker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.